Page last updated: 2024-09-03

phenylalanyl-prolyl-arginine-chloromethyl ketone and glutamyl-glycyl-arginine chloromethyl ketone

phenylalanyl-prolyl-arginine-chloromethyl ketone has been researched along with glutamyl-glycyl-arginine chloromethyl ketone in 1 studies

Compound Research Comparison

Studies
(phenylalanyl-prolyl-arginine-chloromethyl ketone)
Trials
(phenylalanyl-prolyl-arginine-chloromethyl ketone)
Recent Studies (post-2010)
(phenylalanyl-prolyl-arginine-chloromethyl ketone)
Studies
(glutamyl-glycyl-arginine chloromethyl ketone)
Trials
(glutamyl-glycyl-arginine chloromethyl ketone)
Recent Studies (post-2010) (glutamyl-glycyl-arginine chloromethyl ketone)
191423501

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Drobot, DW; Harding, SR; Lyon, AW; Lyon, ME1

Other Studies

1 other study(ies) available for phenylalanyl-prolyl-arginine-chloromethyl ketone and glutamyl-glycyl-arginine chloromethyl ketone

ArticleYear
Evaluation of the thrombin inhibitor D-phenylalanyl-L-prolyl-L-arginine chloromethylketone (PPACK) with the factor Xa inhibitor 1,5-dansyl-L-glutamyl-L-glycyl-L-arginine chloromethylketone (GGACK) as anticoagulants for critical care clinical chemistry spe
    Clinica chimica acta; international journal of clinical chemistry, 1999, Volume: 280, Issue:1-2

    Topics: Amino Acid Chloromethyl Ketones; Anticoagulants; Antithrombins; Artifacts; Critical Care; Drug Evaluation; Factor Xa Inhibitors; Humans; Specimen Handling

1999